US FDA Warning Letter Salvo: No Such Thing As Approved OTC Skin-Lightening Product
The FDA issued warning letters to a dozen companies about marketing OTC skin-lightening products containing hydroquinone. While the agency’s stance was friendlier toward such products when it launched the OTC drug review program 40 years ago, the program has changed, and so have the FDA’s views on hydroquinone.
You may also be interested in...
CIR’s 161st Expert Panel Meeting: Much Ado About Airbrush Cosmetics; Prostaglandins Make 2023 Priorities
Exactly what is in airbrush-delivered cosmetics, and how they are used by consumers, are not well understood by Cosmetic Ingredient Review, its expert panel, or the US FDA. At their June meeting, CIR’s independent experts debated who should be responsible for assessing airbrush cosmetics and how safety unknowns should be communicated.
Even when it comes to foreign-manufactured cosmetics containing undeclared ingredients listed under California’s Prop 65, online marketplaces the likes of Amazon can be responsible for providing exposure warnings to consumers, according to California’s First Appellate District.
The FDA must report to the House Appropriations Committee on any work toward defining “natural” cosmetics and on the health effects of talc, asbestos and lead in cosmetic products. The committee’s 2021 FDA spending bill report also cites concerns about skin-lightening products containing “dangerous levels of mercury and hydroquinone.”